SCHEMBL3786267

SCHEMBL3786267

CC(=O)SOc1cc(N)cc(-c2ccccc2N)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
HSD17B10 Q99714 3/20 0.37
BRD4 O60885 2/20 0.37
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
LMNA P02545 3/20 0.34
MAPT P10636 3/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HDAC9 Q9UKV0 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33
GAA P10253 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3787831 0.86 ALDH1A1 (0.41) ALDH1A1HSD17B10BRD4MEN1KMT2A
SCHEMBL3788301 0.84 ALDH1A1 (0.44) ALDH1A1HSD17B10BRD4MAPTL3MBTL1
SCHEMBL3787378 0.84 MAOA (0.39) ALDH1A1HSD17B10MEN1KMT2ALMNA
SCHEMBL3790536 0.82 BACE1 (0.49) ALDH1A1HSD17B10BRD4MEN1KMT2A
SCHEMBL3789932 0.79 MAOA (0.42) ALDH1A1MEN1
SCHEMBL3786201 0.79 ALDH1A1 (0.39) ALDH1A1HSD17B10BRD4MEN1KMT2A
SCHEMBL5045614 0.79 ALDH1A1 (0.39) ALDH1A1HSD17B10BRD4MEN1KMT2A
SCHEMBL3792815 0.79 CYP19A1 (0.39) ALDH1A1HSD17B10MEN1KMT2ALMNA
SCHEMBL3784752 0.77 ALDH1A1 (0.38) ALDH1A1HSD17B10BRD4MEN1KMT2A
SCHEMBL3793664 0.77 ALDH1A1 (0.37) ALDH1A1HSD17B10BRD4LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 ALDH1A1 4339/4885HSD17B10 1100/4885BRD4 96/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.